The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AMARIN CORP PLC SPONSORED ADR 023111404   20,153,788 1,242,527 SH   SOLE   1,242,527 0 0
CYTOKINETICS INC COM NEW 23282W605   19,439,315 588,357 SH   SOLE   588,357 0 0
INNOVIVA INC COM 45781M101   56,573,882 2,816,022 SH   SOLE   2,816,022 0 0
IRONWOOD PHARMACEUTICALS INC COM CL A 46333X108   11,417,419 15,919,435 SH   SOLE   15,919,435 0 0
LANTHEUS HLDGS INC COM 516544103   7,879,107 96,251 SH   SOLE   96,251 0 0
NEUROCRINE BIOSCIENCES INC COM 64125C109   38,103,049 303,151 SH   SOLE   303,151 0 0
VOR BIOPHARMA INC COM 929033108   822,986 508,016 SH   SOLE   508,016 0 0